Literature DB >> 32108223

The TEMPI syndrome.

David B Sykes1, Casey O'Connell2, Wilfried Schroyens3.   

Abstract

The TEMPI syndrome is a rare and acquired disorder characterized by 5 salient features, which compose its name: (1) telangiectasias; (2) elevated erythropoietin and erythrocytosis; (3) monoclonal gammopathy; (4) perinephric fluid collections; and (5) intrapulmonary shunting. Complete resolution of symptoms following treatment with plasma cell-directed therapy supports the hypothesis that the monoclonal antibody is causal and pathogenic. Understanding the basis of the TEMPI syndrome will depend on the identification of additional patients and a coordinated international effort.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32108223     DOI: 10.1182/blood.2019004216

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

2.  Monoclonal gammopathies of clinical significance.

Authors:  Angela Dispenzieri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 3.  Diagnosis and management of monoclonal gammopathy of clinical significance.

Authors:  Hyungwoo Cho
Journal:  Blood Res       Date:  2022-04-30

4.  Diffuse telangiectasia: A clue to the TEMPI syndrome.

Authors:  Yeping Ruan; Xiaoqing Zhao; Meng Pan
Journal:  JAAD Case Rep       Date:  2021-02-27

Review 5.  JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views.

Authors:  Naseema Gangat; Natasha Szuber; Animesh Pardanani; Ayalew Tefferi
Journal:  Leukemia       Date:  2021-05-21       Impact factor: 11.528

6.  Rare disorders have many faces: in silico characterization of rare disorder spectrum.

Authors:  Simona D Frederiksen; Vladimir Avramović; Tatiana Maroilley; Anna Lehman; Laura Arbour; Maja Tarailo-Graovac
Journal:  Orphanet J Rare Dis       Date:  2022-02-22       Impact factor: 4.123

7.  Potential limitations of diagnostic standard codes to distinguish polycythemia vera and secondary erythrocytosis.

Authors:  Alanna Barrios-Ruiz; Daniel Davila-Gonzalez; Eric Fountain; Lee Cheng; Srdan Verstovsek; Cristhiam M Rojas-Hernandez
Journal:  Sci Rep       Date:  2022-03-18       Impact factor: 4.379

8.  Ocular involvement in TEMPI syndrome.

Authors:  Jo-Hsuan Wu; Narine Viruni; Justin Chun; Satish Shanbhag; T Y Alvin Liu
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-10

9.  Multiple myeloma and primary erythrocytosis in a dog.

Authors:  Marianna Ricci; Giulia De Feo; Martin Konar; George Lubas
Journal:  Can Vet J       Date:  2021-08       Impact factor: 1.008

10.  Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome.

Authors:  Chunyan Sun; Jian Xu; Bo Zhang; Haifan Huang; Lei Chen; Han Yan; Aoshuang Xu; Fei Zhao; Daijuan Huang; Liqiong Liu; Jian Li; Yu Hu
Journal:  Blood Adv       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.